DE69808475T2 - Aminosäurederivate zur behandlung von schlaganfall - Google Patents

Aminosäurederivate zur behandlung von schlaganfall

Info

Publication number
DE69808475T2
DE69808475T2 DE69808475T DE69808475T DE69808475T2 DE 69808475 T2 DE69808475 T2 DE 69808475T2 DE 69808475 T DE69808475 T DE 69808475T DE 69808475 T DE69808475 T DE 69808475T DE 69808475 T2 DE69808475 T2 DE 69808475T2
Authority
DE
Germany
Prior art keywords
amino acid
acid derivatives
treating stroke
treating
stroke
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69808475T
Other languages
English (en)
Other versions
DE69808475D1 (de
Inventor
H Harris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Corp Technologies Inc
Original Assignee
Research Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp Technologies Inc filed Critical Research Corp Technologies Inc
Publication of DE69808475D1 publication Critical patent/DE69808475D1/de
Application granted granted Critical
Publication of DE69808475T2 publication Critical patent/DE69808475T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
DE69808475T 1997-07-15 1998-07-15 Aminosäurederivate zur behandlung von schlaganfall Expired - Lifetime DE69808475T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5268497P 1997-07-15 1997-07-15
PCT/US1998/014449 WO1999003460A1 (en) 1997-07-15 1998-07-15 Amino acid derivatives useful to treat stroke

Publications (2)

Publication Number Publication Date
DE69808475D1 DE69808475D1 (de) 2002-11-07
DE69808475T2 true DE69808475T2 (de) 2003-01-30

Family

ID=21979231

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69808475T Expired - Lifetime DE69808475T2 (de) 1997-07-15 1998-07-15 Aminosäurederivate zur behandlung von schlaganfall

Country Status (10)

Country Link
US (1) US6133261A (de)
EP (1) EP0996435B1 (de)
JP (1) JP4213339B2 (de)
AT (1) ATE225171T1 (de)
AU (1) AU744899B2 (de)
CA (1) CA2296560C (de)
DE (1) DE69808475T2 (de)
DK (1) DK0996435T3 (de)
ES (1) ES2184300T3 (de)
WO (1) WO1999003460A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE357227T1 (de) 2000-08-25 2007-04-15 Res Corp Technologies Inc Verwendung von aminosäurehältigen antikonvulsiva zur behandlung von schmerz
PL1689378T3 (pl) * 2003-12-02 2009-09-30 Sanol Arznei Schwarz Gmbh Nowe zastosowanie związków peptydowych do leczenia ośrodkowego bólu neuropatycznego
CA2562937A1 (en) * 2004-04-16 2005-10-27 Schwarz Pharma Ag Use of peptidic compounds for the prophylaxis and treatment of chronic headache
WO2005113579A1 (en) * 2004-05-21 2005-12-01 Mpex Pharmaceuticals, Inc. Bacterial efflux pump inhibitors and methods of treating bacterial infections
US7879795B2 (en) 2004-05-21 2011-02-01 Mpex Pharmaceuticals, Inc. Enhancement of tigecycline potency using efflux pump inhibitors
US20060252749A1 (en) * 2005-01-28 2006-11-09 Srz Properties, Inc. Lacosamide for add-on therapy of psychosis
US20070043120A1 (en) * 2005-08-18 2007-02-22 Bettina Beyreuther Therapeutic combination for painful medical conditions
EP1754476A1 (de) * 2005-08-18 2007-02-21 Schwarz Pharma Ag Lacosamid (SPM 927) zur Behandlung von Myalgien, z.B. Fibromyalgie
EP2992891B1 (de) 2006-06-15 2020-08-05 UCB Pharma GmbH Pharmazeutische zusammensetzung enthaltend brivaracetam und lacosamide mit synergistischer antikonvulsiver wirkung
US8178490B2 (en) * 2007-05-11 2012-05-15 Rempex Pharmaceuticals, Inc. Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
JP6027539B2 (ja) 2010-12-02 2016-11-16 ウーツェーベー ファルマ ゲーエムベーハーUcb Pharma Gmbh ラコサミドの1日1回投与用製剤
EP2468261A1 (de) 2010-12-02 2012-06-27 UCB Pharma GmbH Formulierung von Lacosamid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654301A (en) * 1985-02-15 1997-08-05 Research Corporation Technologies, Inc. Amino acid derivative anticonvulsant
US5378729A (en) * 1985-02-15 1995-01-03 Research Corporation Technologies, Inc. Amino acid derivative anticonvulsant
US5331007A (en) * 1987-02-06 1994-07-19 Fisons Corporation Arylalkyl-amines and -amides having anticonvulsant and neuroprotective properties

Also Published As

Publication number Publication date
EP0996435A1 (de) 2000-05-03
ES2184300T3 (es) 2003-04-01
DE69808475D1 (de) 2002-11-07
JP4213339B2 (ja) 2009-01-21
AU744899B2 (en) 2002-03-07
EP0996435B1 (de) 2002-10-02
DK0996435T3 (da) 2003-01-27
ATE225171T1 (de) 2002-10-15
JP2002527350A (ja) 2002-08-27
CA2296560A1 (en) 1999-01-28
AU8397898A (en) 1999-02-10
US6133261A (en) 2000-10-17
WO1999003460A1 (en) 1999-01-28
CA2296560C (en) 2006-12-19

Similar Documents

Publication Publication Date Title
TR200200068T2 (tr) Nematisital triflüorobütenler
EE200000318A (et) Uudsed ühendid
FI961809A (fi) Uudet (R)-5-karbamoyyli-8-fluori-3-N,N-disubstituoitu-amino 3,4-dihydro-2H-1-bentsopyraanit
DE60112766D1 (de) Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen
ATE253063T1 (de) 5-ht1f-agonisten
BR9812837A (pt) Processo para fazer um composto, e, composto
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
DE69325393T2 (de) Pharmazeutische zusammensetzungen und verfahren unter verwendung von isobutyramid zur behandlung von betaglobinerkrankungen
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
ATE303362T1 (de) Chalcon-derivate mit antiproliferativer aktivität
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
BR9811348A (pt) Compostos derivados de indol, processo para preparação dos mesmos, e, composições farmacêuticas.
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
DE69818823D1 (de) Dipohosphonsäuresalze für die behandlung von osteoporose
ATE288909T1 (de) Indolderivate verwendbar zur behandlung von u.a. osteoporosis
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
NO20002408D0 (no) 5-HT1F antagonister
PL336897A1 (en) Novel salts of bpc peptides, pharmaceutic compositions conatining them and method of obtaining such salts
DE69736180D1 (de) Behandlung von manischen erkrankungen
PT950056E (pt) N-(piridinilamino) isoindolinas e compostos relacionados
PT971714E (pt) Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia
DE69807990D1 (de) Verfahren zur Stabilisierung von 4,6-Diaminoresorcin und dessen Salzen
RU93055684A (ru) Соединения, ингибирующие вич-протеазу, способ их получения, фармацевтическая композиция, промежуточный продукт

Legal Events

Date Code Title Description
8364 No opposition during term of opposition